Cargando…

Review on 3D printing: Fight against COVID-19

The outbreak of coronavirus disease in 2019 (COVID-19) caused by the SARS-CoV-2 virus and its pandemic effects have created a demand for essential medical equipment. To date, there are no specific, clinically significant licensed drugs and vaccines available for COVID-19. Hence, mapping out COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Oladapo, Bankole I., Ismail, Sikiru O., Afolalu, Temitope D., Olawade, David B., Zahedi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578746/
https://www.ncbi.nlm.nih.gov/pubmed/33106717
http://dx.doi.org/10.1016/j.matchemphys.2020.123943
_version_ 1783598433403142144
author Oladapo, Bankole I.
Ismail, Sikiru O.
Afolalu, Temitope D.
Olawade, David B.
Zahedi, Mohsen
author_facet Oladapo, Bankole I.
Ismail, Sikiru O.
Afolalu, Temitope D.
Olawade, David B.
Zahedi, Mohsen
author_sort Oladapo, Bankole I.
collection PubMed
description The outbreak of coronavirus disease in 2019 (COVID-19) caused by the SARS-CoV-2 virus and its pandemic effects have created a demand for essential medical equipment. To date, there are no specific, clinically significant licensed drugs and vaccines available for COVID-19. Hence, mapping out COVID-19 problems and preventing the spread with relevant technology are very urgent. This study is a review of the work done till October, 2020 on solving COVID-19 with 3D printing. Many patients who need to be hospitalized because of COVID-19 can only survive on bio-macromolecules antiviral respiratory assistance and other medical devices. A bio-cellular face shield with relative comfortability made of bio-macromolecules polymerized polyvinyl chloride (BPVC) and other biomaterials are produced with 3D printers. Summarily, it was evident from this review study that additive manufacturing (AM) is a proffered technology for efficient production of an improved bio-macromolecules capable of significant COVID-19 test and personal protective equipment (PPE) to reduce the effect of COVID-19 on the world economy. Innovative AM applications can play an essential role to combat invisible killers (COVID-19) and its hydra-headed pandemic effects on humans, economics and society.
format Online
Article
Text
id pubmed-7578746
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-75787462020-10-22 Review on 3D printing: Fight against COVID-19 Oladapo, Bankole I. Ismail, Sikiru O. Afolalu, Temitope D. Olawade, David B. Zahedi, Mohsen Mater Chem Phys Article The outbreak of coronavirus disease in 2019 (COVID-19) caused by the SARS-CoV-2 virus and its pandemic effects have created a demand for essential medical equipment. To date, there are no specific, clinically significant licensed drugs and vaccines available for COVID-19. Hence, mapping out COVID-19 problems and preventing the spread with relevant technology are very urgent. This study is a review of the work done till October, 2020 on solving COVID-19 with 3D printing. Many patients who need to be hospitalized because of COVID-19 can only survive on bio-macromolecules antiviral respiratory assistance and other medical devices. A bio-cellular face shield with relative comfortability made of bio-macromolecules polymerized polyvinyl chloride (BPVC) and other biomaterials are produced with 3D printers. Summarily, it was evident from this review study that additive manufacturing (AM) is a proffered technology for efficient production of an improved bio-macromolecules capable of significant COVID-19 test and personal protective equipment (PPE) to reduce the effect of COVID-19 on the world economy. Innovative AM applications can play an essential role to combat invisible killers (COVID-19) and its hydra-headed pandemic effects on humans, economics and society. Elsevier B.V. 2021-01-15 2020-10-22 /pmc/articles/PMC7578746/ /pubmed/33106717 http://dx.doi.org/10.1016/j.matchemphys.2020.123943 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Oladapo, Bankole I.
Ismail, Sikiru O.
Afolalu, Temitope D.
Olawade, David B.
Zahedi, Mohsen
Review on 3D printing: Fight against COVID-19
title Review on 3D printing: Fight against COVID-19
title_full Review on 3D printing: Fight against COVID-19
title_fullStr Review on 3D printing: Fight against COVID-19
title_full_unstemmed Review on 3D printing: Fight against COVID-19
title_short Review on 3D printing: Fight against COVID-19
title_sort review on 3d printing: fight against covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578746/
https://www.ncbi.nlm.nih.gov/pubmed/33106717
http://dx.doi.org/10.1016/j.matchemphys.2020.123943
work_keys_str_mv AT oladapobankolei reviewon3dprintingfightagainstcovid19
AT ismailsikiruo reviewon3dprintingfightagainstcovid19
AT afolalutemitoped reviewon3dprintingfightagainstcovid19
AT olawadedavidb reviewon3dprintingfightagainstcovid19
AT zahedimohsen reviewon3dprintingfightagainstcovid19